Physician profile
Karyn-Anne B Cumberbatch
NPI 1073618344
$451,933.62
in general payments reported to CMS, 2019-2025
7 companies · $130K in 2025
The $130K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $22K · 2021: $71K · 2022: $95K · 2024: $134K · 2025: $130K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $264K · Travel and Lodging: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $263,682.04 |
| Travel and Lodging | $313.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $260,707.04 | 2024-2025 | |
| Csl Behring | $187,799.96 | 2020-2022 | |
| Eli Lilly and Company | $3,288.45 | 2025 | |
| Duchesnay USA Incorporated | $121.36 | 2019 | |
| Lupin INC. | $16.81 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karyn-Anne Cumberbatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.